Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+15.88%
+2.93%
-0.49%
+17.23%
+0.46%
DHR
Danaher
$192.06
Chart
$184.96 (+3.84%)
$212.84 (-9.76%)
$245.66 (-21.82%)
$254.85 (-24.64%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+15.88%
+2.93%
-0.49%
+17.23%
+0.46%
DHR
Danaher
Current Price
$192.06
Login to view Danaher (DHR) recommendation from the last 90 days from financial news and social media.
Chart
$184.96 (+3.84%)
$212.84 (-9.76%)
$245.66 (-21.82%)
$254.85 (-24.64%)
DHR Latest Headlines
Danaher Partners With AstraZeneca to Support Precision Medicine. DHR and AstraZeneca team up to develop AI-powered diagnostics aiming to boost precision medicine by improving patient selection and making advanced tests accessible worldwide.
Fri May 30, 2025
Danaher Partners With AstraZeneca to Support Precision Medicine. DHR and AstraZeneca team up to develop AI-powered diagnostics aiming to boost precision medicine by improving patient selection and making advanced tests accessible worldwide.
Fri May 30, 2025
Danaher Partners With AstraZeneca to Support Precision Medicine. DHR and AstraZeneca team up to develop AI-powered diagnostics aiming to boost precision medicine by improving patient selection and making advanced tests accessible worldwide.
Fri May 30, 2025
Danaher Partners With AstraZeneca to Support Precision Medicine. DHR and AstraZeneca team up to develop AI-powered diagnostics aiming to boost precision medicine by improving patient selection and making advanced tests accessible worldwide.
Fri May 30, 2025
Danaher in partnership with AstraZeneca for diagnostic tests for precision medicine.
Thu May 29, 2025
Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine. Danaher has entered a partnership with AstraZeneca to scale precision medicine including developing the next generation of AI-powered diagnostics This partnership aims to create a framework for rapid diagnostics research development and commercialization Danaher through its Centers for...
Thu May 29, 2025
Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine. Danaher has entered a partnership with AstraZeneca to scale precision medicine including developing the next generation of AI-powered diagnostics This partnership aims to create a framework for rapid diagnostics research development and commercialization Danaher through its Centers for...
Thu May 29, 2025
Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine. Danaher has entered a partnership with AstraZeneca to scale precision medicine including developing the next generation of AI-powered diagnostics This partnership aims to create a framework for rapid diagnostics research development and commercialization Danaher through its Centers for...
Thu May 29, 2025
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today. Danaher (NYSE:) has outperformed the market over the past 10 years by 1.68% on an annualized basis producing an average annual return of 12.54%. Currently Danaher has a market capitalization of $135.98 billion.
Wed May 28, 2025
Market Whales and Their Recent Bets on DHR Options. High-rolling investors have positioned themselves bearish on Danaher (NYSE:) and it'.s important for retail traders to take note.\This activity came to our attention today through Benzinga'.s tracking of publicly available options data. The identities of these investors are uncertain but such a significant move in DHR often signals that someone has privileged information.Today Benzinga'.s options scanner spotted 13 options trades fo
Wed May 21, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
